Literature DB >> 2827912

Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart.

F T Thandroyen1, J McCarthy, K P Burton, L H Opie.   

Abstract

This study investigates the possible role of oscillatory release of calcium from sarcoplasmic reticulum in the genesis of ventricular arrhythmias during acute myocardial ischemia and reperfusion in isolated rat hearts. We used ryanodine and caffeine, which are known to modulate the oscillatory release of calcium from sarcoplasmic reticulum. During 30 minutes of left main coronary artery ligation, all 13 control hearts developed ventricular premature beats (number of beats, 225 +/- 51) and ventricular tachycardia (duration, 123 +/- 21 seconds); five hearts developed ventricular fibrillation. In a separate series of experiments, reperfusion after 15 minutes of coronary artery ligation caused ventricular fibrillation to occur within 15 seconds in all 12 hearts. Ryanodine (10(-9) to 10(-7) M) abolished ventricular arrhythmias during coronary artery ligation and prevented reperfusion ventricular fibrillation. Ryanodine (10(-9), 10(-8), and 10(-7) M) caused 15%, 23%, and 74% decreases in the maximal rate of rise of left ventricular pressure development and 20%, 32%, and 85% decreases in the maximal rate of fall of left ventricular pressure development, respectively, prior to coronary artery ligation. During acute myocardial ischemia, ryanodine 10(-9) M maintained and 10(-8) M impaired left ventricular function; 10(-7) M caused left ventricular failure. Coronary perfusion rate did not increase during ischemia. Antiarrhythmic activity occurred independent of preservation of high energy phosphates, reduction in tissue lactate, or tissue cyclic adenosine monophosphate in the ischemic myocardium. Caffeine 10(2) M decreased the incidence of ventricular arrhythmias during ischemia and upon reperfusion; protection occurred coincident with development of diastolic contracture. Caffeine increased ischemic tissue cyclic adenosine monophosphate content and worsened tissue energy status.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827912     DOI: 10.1161/01.res.62.2.306

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart.

Authors:  M G Worthington; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

Review 2.  Local myocardial biochemical and ionic alterations during myocardial ischaemia and reperfusion.

Authors:  L S Gettes; W E Cascio; T Johnson; W F Fleet
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium.

Authors:  J A Lee; D G Allen
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

4.  Effects of pretreatment with caffeine or ryanodine on the myocardial response to simulated ischaemia.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

Review 5.  Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention.

Authors:  L H Opie; W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

6.  Sexual dimorphism in rat left atrial function and response to adrenergic stimulation.

Authors:  D W Schwertz; V Vizgirda; R J Solaro; M R Piano; C Ryjewski
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

7.  Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.

Authors:  A J D'Alonzo; J C Sewter; R B Darbenzio; T A Hess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

Review 8.  Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.

Authors:  Sandor Györke; Cynthia Carnes
Journal:  Pharmacol Ther       Date:  2008-07-12       Impact factor: 12.310

Review 9.  Calcium channel antagonists. Part V: Second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

Review 10.  Oxidative substrate metabolism during postischemic reperfusion.

Authors:  R Lerch
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.